BNB PLUS CORP. (BNBX): Nasdaq/NYSE listing notice — Applied DNA Sciences receives Nasdaq equity deficiency notice; equity negative $175K

BNB PLUS CORP.

As of March 31, 2024, stockholders' equity was negative $175,385, below the $2.5M minimum for Nasdaq Capital Market.
Company must submit a compliance plan by July 1, 2024 to regain compliance with Nasdaq Listing Rule 5550(b)(1).
Nasdaq may grant up to 180-day extension if plan accepted; no guarantee of acceptance or eventual compliance.
Letter has no immediate effect on listing; company is evaluating options.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

BNB PLUS CORP. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

(the “Stockholders’ Equity Requirement”). In the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, the Company reported stockholders’ equity of ($175,385), which was below the Stockholders’ Equity Requirement. In accordance with Nasdaq rules, the Company has 45 calendar days, or until July 1, 2024, to submit a plan to the Staff to

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BNB PLUS CORP. filing history →

Source: SEC EDGAR

accession 0001104659-24-062618

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.